PRODUCT LITERATURE

Effects of febuxostat on renal function in patients with chronic kidney disease : A systematic review and meta-analysis

---

Hyperuricemia has been proven to be an independent risk factor for chronic kidney disease (CKD).
However, the role of hyperuricemia in the progression of CKD remains unclear. Thus, we performed a systematic review and metaanalysis to evaluate the efficacy and safety of febuxostat, a first line urate-lowering agent, in CKD patients with hyperuricemia

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Festaric
Febuxostat
Chronic Kidney Disease
Renal function

Specific Detail Info

Medicine (2019) 98:29(e16311)

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment